These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26485258)

  • 41. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cryptic Plasmodium ovale concurrent with mixed Plasmodium falciparum and Plasmodium malariae infection in two children from Central African Republic.
    Bichara C; Flahaut P; Costa D; Bienvenu AL; Picot S; Gargala G
    Malar J; 2017 Aug; 16(1):339. PubMed ID: 28810865
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacology of atovaquone and proguanil hydrochloride.
    Beerahee M
    J Travel Med; 1999 May; 6 Suppl 1():S13-7. PubMed ID: 23573547
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atovaquone plus proguanil is an effective treatment for Plasmodium ovale and P. malariae malaria.
    Radloff PD; Philipps J; Hutchinson D; Kremsner PG
    Trans R Soc Trop Med Hyg; 1996; 90(6):682. PubMed ID: 9015517
    [No Abstract]   [Full Text] [Related]  

  • 45. Antimalarial pharmacology and therapeutics of atovaquone.
    Nixon GL; Moss DM; Shone AE; Lalloo DG; Fisher N; O'Neill PM; Ward SA; Biagini GA
    J Antimicrob Chemother; 2013 May; 68(5):977-85. PubMed ID: 23292347
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abbreviated atovaquone-proguanil prophylaxis regimens in travellers after leaving malaria-endemic areas: A systematic review.
    Savelkoel J; Binnendijk KH; Spijker R; van Vugt M; Tan K; Hänscheid T; Schlagenhauf P; Grobusch MP
    Travel Med Infect Dis; 2018; 21():3-20. PubMed ID: 29242073
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the potential for discontinuing atovaquone-proguanil (AP) ad-hoc post-exposure and other abbreviated AP-regimens: Pharmacology, pharmacokinetics and perspectives.
    Schnyder JL; de Jong HK; Bache EB; van Hest RM; Schlagenhauf P; Borrmann S; Hanscheid T; Grobusch MP
    Travel Med Infect Dis; 2023; 52():102520. PubMed ID: 36526126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel Endochin-Like Quinolones Exhibit Potent
    van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Malaria--chemoprophylaxis 2001].
    Hatz FR; Beck B; Blum J; Funk M; Furrer H; Genton B; Holzer B; Loutan L; Markwalder K; Raeber PA; Schlagenhauf P; Siegl G; Steffen R; Stürchler D; Wyss R
    Ther Umsch; 2001 Jun; 58(6):347-51. PubMed ID: 11441694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atovaquone-proguanil resistance in imported falciparum malaria in a young child.
    Rose GW; Suh KN; Kain KC; Le Saux N; McCarthy AE
    Pediatr Infect Dis J; 2008 Jun; 27(6):567-9. PubMed ID: 18434932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb).
    Gil JP; Nogueira F; Strömberg-Nörklit J; Lindberg J; Carrolo M; Casimiro C; Lopes D; Arez AP; Cravo PV; Rosário VE
    Mol Cell Probes; 2003; 17(2-3):85-9. PubMed ID: 12788029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recrudescing Plasmodium malariae infection despite appropriate treatment in an immigrant toddler.
    Islam S; Hai F
    Paediatr Int Child Health; 2018 Nov; 38(4):290-293. PubMed ID: 28975859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malaria surveillance--United States, 2009.
    Mali S; Tan KR; Arguin PM; ;
    MMWR Surveill Summ; 2011 Apr; 60(3):1-15. PubMed ID: 21508921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytochrome b mutation Y268S conferring atovaquone resistance phenotype in malaria parasite results in reduced parasite bc1 catalytic turnover and protein expression.
    Fisher N; Abd Majid R; Antoine T; Al-Helal M; Warman AJ; Johnson DJ; Lawrenson AS; Ranson H; O'Neill PM; Ward SA; Biagini GA
    J Biol Chem; 2012 Mar; 287(13):9731-9741. PubMed ID: 22282497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amplicon Deep Sequencing Reveals Multiple Genetic Events Lead to Treatment Failure with Atovaquone-Proguanil in Plasmodium falciparum.
    Castañeda-Mogollón D; Toppings NB; Kamaliddin C; Lang R; Kuhn S; Pillai DR
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0170922. PubMed ID: 37154745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What is the value of the combination atovaquone-proguanil for the clinician?].
    Delmont J
    Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Causal prophylactic efficacy of primaquine, tafenoquine, and atovaquone-proguanil against Plasmodium cynomolgi in a rhesus monkey model.
    DiTusa C; Kozar MP; Pybus B; Sousa J; Berman J; Gettayacamin M; Im-erbsin R; Tungtaeng A; Ohrt C
    J Parasitol; 2014 Oct; 100(5):671-3. PubMed ID: 24780070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.